Target Price | €7.73 |
Price | €3.25 |
Potential |
137.54%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Valneva 2026 .
The average Valneva target price is €7.73.
This is
137.54%
register free of charge
€10.00
207.31%
register free of charge
€2.95
9.34%
register free of charge
|
|
A rating was issued by 8 analysts: 7 Analysts recommend Valneva to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Valneva stock has an average upside potential 2026 of
137.54%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 153.71 | 182.40 |
57.46% | 18.66% | |
EBITDA Margin | -56.27% | 20.50% |
93.97% | 136.43% | |
Net Margin | -77.01% | -8.45% |
38.38% | 89.03% |
7 Analysts have issued a sales forecast Valneva 2024 . The average Valneva sales estimate is
This results in the following potential growth metrics:
2 Valneva Analysts have issued a net profit forecast 2024. The average Valneva net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | -0.73 | -0.10 |
41.13% | 86.30% | |
P/E | negative | |
EV/Sales | 3.18 |
2 Analysts have issued a Valneva forecast for earnings per share. The average Valneva <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Valneva stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
RX SECURITIES |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
BRYAN GARNIER |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Oct 17 2024 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Sep 24 2024 |
Analyst Rating | Date |
---|---|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Jan 05 2025 |
Locked
BRYAN GARNIER:
Locked
➜
Locked
|
Dec 18 2024 |
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Dec 02 2024 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Nov 06 2024 |
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Oct 17 2024 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Sep 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.